Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome. (Q51493055)
Jump to navigation
Jump to search
scientific article published on 30 June 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome. |
scientific article published on 30 June 2006 |
Statements
1 reference
Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome. (English)
1 reference
1 reference
Ralph DeFronzo
1 reference
Rachele Berria
1 reference
Scott Lucidi
1 reference
Renata Belfort
1 reference
Eleanna De Filippis
1 reference
Caraan Easton
1 reference
Robert Brytzki
1 reference
Kenneth Cusi
1 reference
Lois Jovanovic
1 reference
30 June 2006
1 reference
80
1 reference
2
1 reference
105-114
1 reference
Identifiers
1 reference